Unani formulation in fungal infection

Efficacy of Natroon Banjawi and Sirka as Zimad in Tinea corporis-A pilot study - Tinea corporis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/09/036600

Enrollment

Registered

2021-09-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: Natroon banjawi and Sirka : In the patient of tinea corporis Natroon banjawi and Sirka made in the form of paste, applied locally for about 15-20 mints and then washed off. Dura

Eligibility

Inclusion criteria

Inclusion criteria: Patient of tinea corporis attending OPD of NIUM hospital (Confirmed by direct microscopy). Patient of either gender. Age group 18-60 years. Patient who have agreed to sign the informed consent form, comply with the study procedure, and availability for regular follow up during the protocol.

Exclusion criteria

Exclusion criteria: Patient below 18 years and above 60 years of age Patient with sever systemic illness like Diabetic, malignancy etc HIV/AIDS or other immunocompromised patients Patient with other skin diseases like Erythrasma, Candida intertrigo, Intertriginous Psoriasis, Pityriasis versicolor.

Design outcomes

Primary

Measure	Time frame
Improvement in subjective parametersTimepoint: 21 days	—

Secondary

Measure	Time frame
Improvement in objective parameters (Negative KOH preparation.)Timepoint: baseline to end of the treatment	—

Countries

India

Contacts

Public ContactProf Mohd Aleemuddin Quamri

National Institute of Unani Medicine

drshameemkazi@gmail.com8792796104

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026